New heart valve procedure shows promise for Low-Risk patients
NCT ID NCT07605780
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 650 low-risk patients with severe aortic valve narrowing who received a less invasive valve replacement called TAVI. Researchers tracked deaths, strokes, and return hospital visits for heart problems. The goal was to see how well TAVI works in everyday practice for people not at high surgical risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione Poliambulanza Istituto Ospedaliero, Unità Emodinamica
Brescia, BS, 25124, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single stitch beat a double closure for TAVI patients?
- Can a fitness app boost recovery after heart valve replacement?
- A new heart valve without Open-Heart surgery: can it help High-Risk patients?
- Can a single antiplatelet drug beat aspirin after heart valve replacement?
- Can common heart-surgery practices trigger delirium? a 5,600-patient hunt for clues.
- Which heart valve works best for small aortic openings? a Head-to-Head trial